Home › Malattia di Crohn › Texas › Lubbock
Studi clinici su Malattia di Crohn a Lubbock, TX
10 studi su Malattia di Crohn cercano partecipanti presso sedi a Lubbock e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
In reclutamentoFase 3
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
In reclutamentoFase 3
- Caprock Gastro Research ( Site 5077), Lubbock
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
In reclutamentoFase 2
- GI Alliance - Lubbock /ID# 283920, Lubbock
- Caprock Gastro Research - Lubbock /ID# 283921, Lubbock
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
In reclutamentoFase 4
- West Texas Research Institute, Lubbock
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
In reclutamentoFase 2
- Caprock Gastro Research - Lubbock /ID# 265541, Lubbock
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 3
- Lubbock Gastroenterology, Lubbock
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 3
- GI Alliance - Lubbock-Site Number: 8400092, Lubbock
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 3
- GI Alliance - Lubbock-Site Number: 8400092, Lubbock
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
In reclutamentoFase 4
- Texas Digestive Disease Consultants Lubbock, Lubbock
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
In reclutamentoFase 2
- Mirador Therapeutics Selected Site, Lubbock
Studi su Malattia di Crohn in altre città
- New York City, NY35 studi
- Cleveland, OH19 studi
- St. Louis, MO19 studi
- Boston, MA19 studi
- Miami, FL19 studi
- Orlando, FL17 studi
- Houston, TX17 studi
- Atlanta, GA17 studi
- Tyler, TX16 studi
- San Diego, CA15 studi
- San Antonio, TX15 studi
- Los Angeles, CA15 studi
Altri studi a Lubbock
- Colite ulcerosa9 studi
- Cancro al seno6 studi
- Cancro del polmone non a piccole cellule4 studi
- Artrite psoriasica3 studi
- Ictus3 studi
- Sovrappeso3 studi
- Obesità3 studi
- Malattia infiammatoria intestinale3 studi
- Linfoma di Burkitt3 studi
- Mieloma multiplo3 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.